logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
Journal of Medical Economics cover

Journal of Medical Economics

IF3
Papers385
Citations3584
Journal Papers 378
Publication Date
delete
Real-world treatment patterns, healthcare resource utilization, and costs associated with high-risk endometrial cancer in England: a retrospective cohort study
deleteJournal of Medical Economics
IF3
delete2026-10-01
delete0
deleteOAAI
deleteEleanor Ralphs; Vimalanand S. Prabhu; Erik Landfeldt; Jess Ridsdale-Smith; Cheryl Teoh; Karen Macey; Nikolay Trankov; Alexandrina Lambova; Jasmine Lichfield; Gemma Eminowicz
deleteShare
deleteSave
Cost-effectiveness of Orca-T vs allo-HCT with conventional GVHD prophylaxis for the treatment of advanced hematologic malignancies in the United States
deleteJournal of Medical Economics
IF3
delete2026-09-29
delete0
deleteOAAI
deleteRawan Faramand; James Scott McClellan; Anna Pavlova; Rocio Manghani; Andrea Blank; Matia Saeedian; Shivani Yadav; Miguel-Angel Perales
deleteShare
deleteSave
Assessing the consistency of overall survival extrapolations in Swedish health technology assessment reports of oncology treatments using extended follow-up data
deleteJournal of Medical Economics
IF3
delete2026-09-26
delete0
deleteOAAI
deleteMáté Szilcz; Olof Mogard; Mattias Ekman; Olof Lindgren; Fredrik Nilsson; Kasper Johannesen; Emma Medin
deleteShare
deleteSave
Cost comparison of intravenous immunoglobulin and subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyneuropathy
deleteJournal of Medical Economics
IF3
delete2026-09-21
delete0
deleteOAAI
deleteSuraj A. Muley; Irene Gucciardi; Vivek Kaisare; Christoph Wissmann; Sarah Bandy; Wei-Shi Yeh; Leslie Myers
deleteShare
deleteSave
Clinical and economic value of onabotulinumtoxinA vs oral pharmacotherapies in overactive bladder in the United States
deleteJournal of Medical Economics
IF3
delete2026-09-21
delete0
deleteOAAI
deleteDoreen E. Chung; Benjamin M. Brucker; Stephen Chaplin; Qianyi Li; Ritu Singh; Erika Wissinger; Annaliza Dominguez
deleteShare
deleteSave
Incidence of comorbidities, healthcare resource utilization and costs among people with HIV
deleteJournal of Medical Economics
IF3
delete2026-09-21
delete0
deleteOAAI
deleteJoshua P. Cohen; Mary J. Christoph; Vamshi Ruthwik Anupindi; Nazneen Fatima Shaikh; JeanPierre Coaquira; Uche Mordi; Kristen Haloski; Alice Hsiao; Aimee M. Near
deleteShare
deleteSave
Retrospective database analysis of annual direct costs and complications for patients with type 1 diabetes and hypoglycemia in the US
deleteJournal of Medical Economics
IF3
delete2026-09-11
delete0
deleteOAAI
deleteAdriana Boateng-Kuffour; Nanxin Li; Vamshi Ruthwik Anupindi; Keval Chandarana; Liang Chen; Michael Hull; Xiaoyu Zhou; Jason L. Gaglia; Mitch Dekoven; Beth Barber
deleteShare
deleteSave
Projected burden of bloodstream infections and the impact of molecular rapid diagnostic testing on costs and mortality in England and the United States (2025–2029): a population-level budget impact analysis
deleteJournal of Medical Economics
IF3
delete2026-09-10
delete0
deleteOAAI
deleteJames K. Karichu; Mark Pennington; Kiera Lander; Tiffeny T. Smith; Adam Thornberg
deleteShare
deleteSave
Cost-effectiveness analysis of pneumococcal vaccination of at-risk and high-risk adults aged 18–64 years in Switzerland using PCV21
deleteJournal of Medical Economics
IF3
delete2026-09-10
delete0
deleteOAAI
deleteMuloongo Simuzingili; Zinan Yi; Andrea Favre-Bulle; Thomas Mutschler; Eleana Tsoumani; Kwame Owusu-Edusei
deleteShare
deleteSave
Societal and fiscal gains from HPV vaccination in Poland – return on investment from extending access to HPV vaccination
deleteJournal of Medical Economics
IF3
delete2026-09-09
delete0
deleteOAAI
deleteRafal Jaworski; Nikolaos Kotsopoulos; Marcin Czech; Mark P. Connolly; Andrew Pavelyev; Alicja Wojcik; Ugne Sabale
deleteShare
deleteSave
Cost-effectiveness analysis of elranatamab versus physician’s choice of treatment (non–BCMA-directed regimens) in patients with triple class exposed multiple myeloma in Japan
deleteJournal of Medical Economics
IF3
delete2026-09-08
delete0
deleteOAAI
deleteAkira Yuasa; Mitsuhiro Nagano; Yoichi Kamei; Kengo Hatsuyama; Hiroyuki Matsuda; Patrick Hlavacek; Marco DiBonaventura; Kenshi Suzuki
deleteShare
deleteSave
Cost-effectiveness analysis of Cardioform vs. Amplatzer: concerns regarding methodological transparency and interpretation of clinical results
deleteJournal of Medical Economics
IF3
delete2026-09-03
delete0
deleteOAAI
deleteDavid W. Hutton; Anne M. Ryschon; Scott Goates; Jan B. Pietzsch; Lars Søndergaard
deleteShare
deleteSave
Real-world healthcare resource utilization and cost burden of COVID-19 in commercially insured adults at high-risk of severe disease in the US: a retrospective database analysis
deleteJournal of Medical Economics
IF3
delete2026-09-03
delete0
deleteOAAI
deleteTendai Mugwagwa; Benjamin A. Abramoff; Siddharth Karanth; Tram Nham; Ravi K. Goyal; Elizabeth Esterberg; Gurinder S. Sidhu; Alon Yehoshua; Ruth Mokgokong
deleteShare
deleteSave
Response to Hutton et al. letter to the editor
deleteJournal of Medical Economics
IF3
delete2026-09-02
delete0
deleteOAAI
deleteJohn J. Volpi; Lambertus F. Wolters; Timon Louwsma; Mitesh Nakum; Ryan J. Imhoff; Erik J. Landaas
deleteShare
deleteSave
Cost-effectiveness of nicotine metabolite ratio-guided smoking cessation therapy in China: a hybrid decision-analytic modeling study based on real-world data
deleteJournal of Medical Economics
IF3
delete2026-09-01
delete0
deleteOAAI
deleteAnqi Cheng; Min Wang; Yingman Gao; Tingfen Ji; Xuejun Hu; Xue Yu; Yong Qi; Wenli Chen; Suqin Xu; Zhao Liu; Xinmei Zhou; Dan Xiao; Chen Wang
deleteShare
deleteSave
Costs and healthcare resource utilization after COVID-19 hospitalization among US Medicare patients: a retrospective claims analysis
deleteJournal of Medical Economics
IF3
delete2026-09-01
delete0
deleteOAAI
deleteAlon Yehoshua; Rachel M. Black; Anan Zhou; Michelle A. Silver; Yu Han; Santiago M. C. Lopez; Benjamin Yarnoff; Rajeev M. Nepal; Maria M. Fernandez; Mohammad Ashraf Chaudhary; Tara Ahi
deleteShare
deleteSave
Cell and gene therapies in managed care: US payer insights on coverage and financial risk
deleteJournal of Medical Economics
IF3
delete2026-08-31
delete0
deleteOAAI
deleteElias C. Pittos; Joe DePinto
deleteShare
deleteSave
What to expect in 2026–2027: important health economics and outcomes research topics
deleteJournal of Medical Economics
IF3
delete2026-08-21
delete0
deleteOAAI
deleteIvo Abraham; Mickael Hiligsmann; Kenneth K. C. Lee; Giorgio L. Colombo; Leslie Citrome; Mike Gregg
deleteShare
deleteSave
The ongoing challenge of Clostridioides difficile infection in Austria: economic evaluation of two recommended treatment pathways
deleteJournal of Medical Economics
IF3
delete2026-08-19
delete0
deleteOAAI
deleteEvelyn Walter; Marco Voit; Gerald Eichhober; Gordon Spencer; Lei Wang; Vanessa Stadlbauer
deleteShare
deleteSave
The economic impact of pediatric RSV-related lower respiratory tract infection in Germany: evidence from the PAPI study
deleteJournal of Medical Economics
IF3
delete2026-08-18
delete0
deleteOAAI
deleteMoritz Wick; Oliver Damm; Rolf Kramer; Mathieu Bangert; Jessica Baehre; Frank Eberhardt; Grit Barten-Neiner; David Twardella; Mareike Meier-Maiwald; Christine Happle; Martin Wetzke
deleteShare
deleteSave